Consistent with previous studies, our investigation indicated that the 12-weeks PCA administration elicited the decreases in high blood pressure together with restoring vascular function by improving endothelium-dependent vasorelaxation induced by insulin and IGF-1 in aging SHR. The gene discussed is IGF1; the disease is blood pressure trait.